Bioventus expands market access for surgical products with new contract

When Durham-based Bioventus acquired OSTEOAMP – a bone fusion solution – from Advanced Biologics back in 2014, the product was already on contract with Premier, Inc. (Nasdaq: PINC), which has an alliance of 3,750 hospitals and upward of 130,000 other organizations across the U.S. Three years later, Bioventus has secured a new contract with Premier for its full, nine-product surgical portfolio, which includes bone grafts and marrow extraction devices, among other products. The new contract...